"/> Novus Biologicals™ Antigène protéique recombinant… | B-LABO France

Novus Biologicals™ Antigène protéique recombinant ARL15

Réf. : BL-RE-084925Réf. fabricant : 18227302 100μL
242,97 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
54622
Méthode de purification
>80% by SDS-PAGE and Coomassie blue staining
Nom usuel
ARL15 Recombinant Protein Antigen
Contenu et stockage
Store at −20°C. Avoid freeze-thaw cycles.
Formule
PBS and 1M Urea, pH 7.4.
Marque
Novus Biologicals

A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human ARL15.

Points forts

Source

E.coli

Amino Acid Sequence

LHSALQHPQLCTLPFLILANHQDKPAARSVQEIKKYFELEPLARGKRWILQPCSLDDMDALKDSFSQLINLLEEKDHEAVRM The ARL15 Recombinant Protein Antigen is derived from E. coli. The ARL15 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-084925
Réf. fabricant18227302
Gene ID (Entrez)54622
Méthode de purification>80% by SDS-PAGE and Coomassie blue staining
Nom usuelARL15 Recombinant Protein Antigen
Contenu et stockageStore at −20°C. Avoid freeze-thaw cycles.
FormulePBS and 1M Urea, pH 7.4.
À utiliser avec (application)Blocking/Neutralizing, Control
Alias de gèneADP-ribosylation factor related protein 2, ADP-ribosylation factor-like 15, ADP-ribosylation factor-like protein 15, ADP-ribosylation factor-related protein 2, ARF-related protein 2, ARFRP2, FLJ20051
Symbole de gène(s)ARL15
Type d’étiquetteUnlabeled
Type de produitRecombinant Protein Antigen
Quantité100μL
État réglementaireRUO
SourceE.coli
Réactivité spécifiqueThis recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-50590. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml
Une question, une configuration particulière ?
Contactez-nous pour un devis.